Common Contracts
2 similar License Agreement contracts by Idera Pharmaceuticals, Inc.
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. Amendment To The License AgreementLicense Agreement • October 9th, 2009 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
This Amendment, effective the 12th day of February, 2009, (“Amendment Date”) is by and between Idera Pharmaceuticals, Inc., having a place of business located at 167 Sidney Street, Cambridge, Massachusetts 02139 (“Idera”) and Merck KGaA, a general partnership limited by shares organized under German law having a place of business at Frankfurter Strasse 250, 64293 Darmstadt, Germany (“Merck”). Idera and Merck may be referred to collectively as “Parties.”
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. Amendment To The License AgreementLicense Agreement • March 11th, 2009 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances)
This Amendment, effective the 12th day of February, 2009, (“Amendment Date”) is by and between Idera Pharmaceuticals, Inc., having a place of business located at 167 Sidney Street, Cambridge, Massachusetts 02139 (“Idera”) and Merck KGaA, a general partnership limited by shares organized under German law having a place of business at Frankfurter Strasse 250, 64293 Darmstadt, Germany (“Merck”). Idera and Merck may be referred to collectively as “Parties.”
